COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
Background The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood. Methods We analyzed the epidemiological and clinical features of all COVID‐2019 cases in the only referral hospital in Shenzhen City, China, from Ja...
Saved in:
Published in | Allergy (Copenhagen) Vol. 75; no. 7; pp. 1742 - 1752 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Denmark
Blackwell Publishing Ltd
01.07.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood.
Methods
We analyzed the epidemiological and clinical features of all COVID‐2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020.
Results
Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%.
Conclusions
In a designated hospital outside Hubei Province, COVID‐2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.
This study analyzes the epidemiological and clinical features of all 298 COVID‐19 cases in the only referral hospital of Shenzhen City. Slower clearance of virus is associated with a higher progression to severe critical condition. Compared with the nonsevere cases, severe cases are associated with older age, underlying diseases, higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Abbreviations: CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate. |
---|---|
AbstractList | The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood.BACKGROUNDThe clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood.We analyzed the epidemiological and clinical features of all COVID-2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020.METHODSWe analyzed the epidemiological and clinical features of all COVID-2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020.Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C-reactive protein, interleukin-6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%.RESULTSAmong the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C-reactive protein, interleukin-6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%.In a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.CONCLUSIONSIn a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease. BackgroundThe clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood.MethodsWe analyzed the epidemiological and clinical features of all COVID‐2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020.ResultsAmong the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%.ConclusionsIn a designated hospital outside Hubei Province, COVID‐2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease. The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood. We analyzed the epidemiological and clinical features of all COVID-2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020. Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C-reactive protein, interleukin-6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%. In a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease. Background The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood. Methods We analyzed the epidemiological and clinical features of all COVID‐2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020. Results Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%. Conclusions In a designated hospital outside Hubei Province, COVID‐2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease. This study analyzes the epidemiological and clinical features of all 298 COVID‐19 cases in the only referral hospital of Shenzhen City. Slower clearance of virus is associated with a higher progression to severe critical condition. Compared with the nonsevere cases, severe cases are associated with older age, underlying diseases, higher levels of C‐reactive protein, interleukin‐6, and erythrocyte sedimentation rate. Abbreviations: CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate. |
Author | Ma, Zhenghua Li, Zhiwei Chen, Jun Fu, Yang Zhang, Yiming He, Qing Huang, Deliang Su, Yinan Yu, Hong Liu, Lei Cai, Qingxian Zhu, Zhibin Ou, Pengcheng Xia, Zhang |
Author_xml | – sequence: 1 givenname: Qingxian surname: Cai fullname: Cai, Qingxian organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 2 givenname: Deliang surname: Huang fullname: Huang, Deliang organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 3 givenname: Pengcheng surname: Ou fullname: Ou, Pengcheng organization: The First Affiliated Hospital of Southern University of Science and Technology – sequence: 4 givenname: Hong surname: Yu fullname: Yu, Hong organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 5 givenname: Zhibin surname: Zhu fullname: Zhu, Zhibin organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 6 givenname: Zhang surname: Xia fullname: Xia, Zhang organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 7 givenname: Yinan surname: Su fullname: Su, Yinan organization: Southern University of Science and Technology – sequence: 8 givenname: Zhenghua surname: Ma fullname: Ma, Zhenghua organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 9 givenname: Yiming surname: Zhang fullname: Zhang, Yiming organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 10 givenname: Zhiwei surname: Li fullname: Li, Zhiwei organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 11 givenname: Qing surname: He fullname: He, Qing organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 12 givenname: Lei surname: Liu fullname: Liu, Lei email: liulei3322@aliyun.com organization: The Second Affiliated Hospital of Southern University of Science and Technology – sequence: 13 givenname: Yang surname: Fu fullname: Fu, Yang email: fuy@sustech.edu.cn organization: Southern University of Science and Technology – sequence: 14 givenname: Jun orcidid: 0000-0002-9744-792X surname: Chen fullname: Chen, Jun email: drchenjun@163.com organization: The Second Affiliated Hospital of Southern University of Science and Technology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32239761$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1KxDAUhYMoOo4ufAEJuFGwmt9ps5TxZ4QBXajbkCa3GumkY9Mq7nwEn9EnMTrqQtC7uVz4zuFyzjpaDk0AhLYoOaBpDk1dH1DBiVpCA8pVkSml5DIaEEpkJiQv1tB6jPeEkJwpsorWOGNc5SM6QNfji5vz47eXV6qwD9hgB9HfBtOBS3cFtvNNH7HzEUyEiO-aOPedqXHTd9E7wJO-BI8v2-bRBwv7eHzng9lAK5WpI2x-7SG6Pj25Gk-y6cXZ-fhomllRMJVJLpRjShgKfERNKXNDrFSFLYFzk1ecSwkgqVNOMOFGlaMlKwsnCselJcCHaHfhO2-bhx5ip2c-WqhrEyC9rRkvZE6KXNCE7vxC75u-Dek7zQRjgssR-6C2v6i-nIHT89bPTPusvwNLwN4CsG0TYwvVD0KJ_ihDpzL0ZxmJPfzF2hRdCjR0rfH1f4onX8Pz39b6aDpdKN4BNtSZGw |
CitedBy_id | crossref_primary_10_13105_wjma_v11_i1_5 crossref_primary_10_3851_IMP3385 crossref_primary_10_1039_D0AY02304C crossref_primary_10_1186_s13018_020_01702_w crossref_primary_10_3390_jcm10194432 crossref_primary_10_35772_ghm_2020_01025 crossref_primary_10_1016_j_ajem_2020_08_089 crossref_primary_10_1186_s12872_020_01816_3 crossref_primary_10_1093_ndt_gfaa218 crossref_primary_10_1371_journal_pone_0250602 crossref_primary_10_1111_all_16028 crossref_primary_10_3748_wjg_v27_i15_1531 crossref_primary_10_15302_J_QB_020_0230 crossref_primary_10_4254_wjh_v16_i4_517 crossref_primary_10_1016_j_ajem_2020_08_090 crossref_primary_10_1111_all_14647 crossref_primary_10_3748_wjg_v28_i42_6017 crossref_primary_10_3390_vaccines11020460 crossref_primary_10_1080_10410236_2021_1991618 crossref_primary_10_7759_cureus_13894 crossref_primary_10_1515_almed_2022_0037 crossref_primary_10_12688_f1000research_53539_2 crossref_primary_10_7759_cureus_35426 crossref_primary_10_1136_bmjopen_2021_051534 crossref_primary_10_3748_wjg_v29_i16_2397 crossref_primary_10_3389_fcvm_2021_757799 crossref_primary_10_1002_hsr2_274 crossref_primary_10_1016_j_ijmmb_2021_04_007 crossref_primary_10_5468_ogs_20174 crossref_primary_10_1186_s12879_020_05728_7 crossref_primary_10_1016_j_heliyon_2020_e05684 crossref_primary_10_1136_bmjopen_2024_085971 crossref_primary_10_1111_all_15502 crossref_primary_10_1038_s41598_021_02982_w crossref_primary_10_1097_CCM_0000000000004411 crossref_primary_10_5812_hepatmon_104415 crossref_primary_10_4103_NJM_NJM_142_20 crossref_primary_10_1002_jmv_26336 crossref_primary_10_1016_S2213_2600_21_00103_X crossref_primary_10_1155_adph_4456532 crossref_primary_10_1016_S2213_2600_20_30404_5 crossref_primary_10_1080_20477724_2024_2313787 crossref_primary_10_1016_j_ajic_2020_08_013 crossref_primary_10_12688_f1000research_53539_1 crossref_primary_10_1186_s12879_021_05992_1 crossref_primary_10_1007_s13337_023_00818_x crossref_primary_10_12998_wjcc_v9_i16_3814 crossref_primary_10_18632_aging_103383 crossref_primary_10_3390_medicina58121701 crossref_primary_10_7759_cureus_45389 crossref_primary_10_1177_22799036221115779 crossref_primary_10_1177_10815589231158041 crossref_primary_10_2147_IJGM_S327429 crossref_primary_10_3389_fmed_2021_588013 crossref_primary_10_1016_j_metabol_2020_154373 crossref_primary_10_1097_MD_0000000000023315 crossref_primary_10_14218_JCTH_2021_00368 crossref_primary_10_1007_s00415_020_09978_y crossref_primary_10_1016_j_cmi_2020_07_016 crossref_primary_10_4081_monaldi_2021_1694 crossref_primary_10_3748_wjg_v29_i3_425 crossref_primary_10_1002_hsr2_1803 crossref_primary_10_1080_1120009X_2021_1988203 crossref_primary_10_17816_rmmar83626 crossref_primary_10_5114_pjr_2021_103379 crossref_primary_10_1136_jim_2021_001858 crossref_primary_10_1017_ice_2021_391 crossref_primary_10_5005_jp_journals_10024_3076 crossref_primary_10_1155_2023_9955105 crossref_primary_10_1161_CIRCEP_120_008740 crossref_primary_10_3748_wjg_v26_i19_2286 crossref_primary_10_12998_wjcc_v10_i7_2063 crossref_primary_10_3389_fphar_2020_01093 crossref_primary_10_3389_fmed_2020_00301 crossref_primary_10_3389_fmed_2020_00542 crossref_primary_10_4254_wjh_v13_i10_1215 crossref_primary_10_1177_2054358120938573 crossref_primary_10_3390_molecules26216614 crossref_primary_10_1186_s12985_023_02081_4 crossref_primary_10_4103_ijrh_ijrh_106_20 crossref_primary_10_1016_j_ajem_2020_10_022 crossref_primary_10_4103_jfmpc_jfmpc_2527_20 crossref_primary_10_1016_j_jhep_2020_04_042 crossref_primary_10_1111_all_14449 crossref_primary_10_3748_wjg_v27_i7_561 crossref_primary_10_1136_bmjopen_2020_039856 crossref_primary_10_1186_s12879_020_05252_8 crossref_primary_10_12688_f1000research_26186_2 crossref_primary_10_12998_wjcc_v9_i3_528 crossref_primary_10_12688_f1000research_26186_1 crossref_primary_10_1152_physrev_00010_2023 crossref_primary_10_3390_life14111376 crossref_primary_10_3389_fphar_2022_799338 crossref_primary_10_4103_jfmpc_jfmpc_138_22 crossref_primary_10_1111_jvh_13590 crossref_primary_10_1007_s11356_020_10132_4 crossref_primary_10_1038_s41421_020_00231_4 crossref_primary_10_1111_dth_13666 crossref_primary_10_1002_hep_31480 crossref_primary_10_1007_s12016_022_08921_5 crossref_primary_10_1111_all_14453 crossref_primary_10_1111_all_14452 crossref_primary_10_1590_1806_9282_66_s2_13 crossref_primary_10_1002_lt_26194 crossref_primary_10_3389_fpubh_2023_1003352 crossref_primary_10_1371_journal_pone_0253894 crossref_primary_10_1002_clc_23465 crossref_primary_10_1016_j_clon_2020_11_006 crossref_primary_10_3389_fcimb_2022_726263 crossref_primary_10_1055_s_0040_1714369 crossref_primary_10_1002_hep_32582 crossref_primary_10_3390_life14030343 crossref_primary_10_1007_s00148_022_00887_0 crossref_primary_10_1111_all_14465 crossref_primary_10_1155_2021_6594863 crossref_primary_10_1186_s43066_022_00171_6 crossref_primary_10_1136_postgradmedj_2021_139939 crossref_primary_10_11604_pamj_2024_49_2_44247 crossref_primary_10_1186_s12916_020_01726_3 crossref_primary_10_3947_ic_2020_52_3_317 crossref_primary_10_1080_10641963_2020_1867160 crossref_primary_10_1007_s40745_022_00378_9 crossref_primary_10_3389_fneur_2020_00687 crossref_primary_10_3389_fneur_2020_00565 crossref_primary_10_21467_ias_10_1_151_167 crossref_primary_10_3389_fpubh_2020_574915 crossref_primary_10_3390_vaccines11010048 crossref_primary_10_3748_wjg_v26_i22_2987 crossref_primary_10_1111_all_14472 crossref_primary_10_1080_14789450_2023_2191845 crossref_primary_10_1002_rmv_2195 crossref_primary_10_31146_1682_8658_ecg_191_7_6_11 crossref_primary_10_25259_ANAMS_1078_2023 crossref_primary_10_1016_j_jtumed_2022_02_002 crossref_primary_10_1038_s41598_021_88130_w crossref_primary_10_1111_liv_15274 crossref_primary_10_1016_j_cmi_2020_12_018 crossref_primary_10_22516_25007440_713 crossref_primary_10_1111_ijcp_13725 crossref_primary_10_4103_JODP_JODP_16_20 crossref_primary_10_1155_2021_6671291 crossref_primary_10_1111_obr_13095 crossref_primary_10_14218_JCTH_2021_00055 crossref_primary_10_13105_wjma_v9_i2_108 crossref_primary_10_1136_bmjopen_2020_040129 crossref_primary_10_3748_wjg_v27_i28_4504 crossref_primary_10_3851_IMP3382 crossref_primary_10_1515_chem_2021_0049 crossref_primary_10_1111_jvh_13362 crossref_primary_10_12998_wjcc_v9_i22_6178 crossref_primary_10_1016_j_jinf_2020_06_067 crossref_primary_10_1038_s41598_022_16396_9 crossref_primary_10_7759_cureus_12039 crossref_primary_10_1155_2021_7830136 crossref_primary_10_3390_pathogens11040445 crossref_primary_10_1016_j_dsx_2021_102308 crossref_primary_10_1016_j_jfma_2021_05_015 crossref_primary_10_1155_2022_4291758 crossref_primary_10_3390_jcm10030446 crossref_primary_10_4103_ijpm_ijpm_658_21 crossref_primary_10_1186_s43066_021_00131_6 crossref_primary_10_13105_wjma_v8_i5_348 crossref_primary_10_1186_s12879_025_10456_x crossref_primary_10_31590_ejosat_1113302 crossref_primary_10_3390_nu13062060 crossref_primary_10_1136_jclinpath_2020_207023 crossref_primary_10_7759_cureus_47028 crossref_primary_10_1002_rmv_2304 crossref_primary_10_1016_j_dsx_2020_11_011 crossref_primary_10_1097_MEG_0000000000002068 crossref_primary_10_1016_j_clinre_2021_101793 crossref_primary_10_1177_1934578X221142790 crossref_primary_10_1007_s10157_021_02123_7 crossref_primary_10_1111_dth_15521 crossref_primary_10_1080_19932820_2021_2010338 crossref_primary_10_1016_j_aohep_2020_10_001 crossref_primary_10_1155_2021_6658270 crossref_primary_10_1159_000513593 crossref_primary_10_1097_MCG_0000000000001432 crossref_primary_10_4103_singaporemedj_SMJ_2021_111 crossref_primary_10_13181_mji_oa_236992 crossref_primary_10_1055_s_0040_1721292 crossref_primary_10_1002_iid3_1020 crossref_primary_10_1186_s12941_021_00420_3 crossref_primary_10_1016_S2666_5247_20_30172_5 crossref_primary_10_17235_reed_2020_7397_2020 crossref_primary_10_3389_fped_2021_616381 crossref_primary_10_1111_sji_12967 crossref_primary_10_1016_j_cca_2020_06_009 crossref_primary_10_1155_2022_7405448 crossref_primary_10_12677_ACM_2021_115292 crossref_primary_10_12998_wjcc_v9_i23_6608 crossref_primary_10_36472_msd_v9i9_817 crossref_primary_10_3390_tropicalmed8020084 crossref_primary_10_1007_s10620_021_07007_0 crossref_primary_10_1186_s40001_023_01401_2 crossref_primary_10_12998_wjcc_v9_i27_7998 crossref_primary_10_1186_s13054_020_03062_7 crossref_primary_10_2147_IDR_S355742 crossref_primary_10_12998_wjcc_v9_i19_4969 crossref_primary_10_1002_jmv_26737 crossref_primary_10_1016_j_xkme_2020_11_008 crossref_primary_10_1177_1753466620963035 crossref_primary_10_1016_j_snb_2020_129333 crossref_primary_10_1109_ACCESS_2021_3108447 crossref_primary_10_1097_QAI_0000000000003399 crossref_primary_10_1016_j_dsx_2020_04_044 crossref_primary_10_1097_MD_0000000000033294 crossref_primary_10_2147_JPR_S269206 crossref_primary_10_1186_s12879_021_05847_9 crossref_primary_10_3389_fphar_2021_719308 crossref_primary_10_12998_wjcc_v8_i19_4303 crossref_primary_10_2174_0118749445339251241114094239 crossref_primary_10_58854_jicm_1510319 crossref_primary_10_1111_eci_13763 crossref_primary_10_2174_0126667975267776231117052825 crossref_primary_10_4103_1995_7645_315897 crossref_primary_10_4236_jct_2024_153009 crossref_primary_10_3201_eid2902_221098 crossref_primary_10_4103_kjo_kjo_204_21 crossref_primary_10_3389_fmed_2020_00458 crossref_primary_10_1016_j_sapharm_2020_04_032 crossref_primary_10_1017_S0950268820003027 crossref_primary_10_12998_wjcc_v10_i36_13148 crossref_primary_10_1183_13993003_00562_2020 crossref_primary_10_1016_j_ajem_2020_09_018 crossref_primary_10_1007_s00251_020_01179_1 crossref_primary_10_1097_MD_0000000000022971 crossref_primary_10_4081_monaldi_2021_1610 crossref_primary_10_3389_fmed_2021_629296 crossref_primary_10_1016_j_jiph_2021_02_011 crossref_primary_10_7759_cureus_29198 crossref_primary_10_1038_s41392_022_00907_1 crossref_primary_10_1002_edm2_338 crossref_primary_10_1111_ijlh_13336 crossref_primary_10_1097_RCT_0000000000001354 crossref_primary_10_1177_11772719221106600 crossref_primary_10_1038_s41366_021_00776_8 crossref_primary_10_1007_s12016_021_08908_8 crossref_primary_10_2139_ssrn_3951144 crossref_primary_10_1002_jcla_23483 crossref_primary_10_1016_j_gtc_2022_09_001 crossref_primary_10_1111_obr_13149 crossref_primary_10_2174_1381612827666210311141512 crossref_primary_10_2807_1560_7917_ES_2021_26_14_2001506 crossref_primary_10_1515_biol_2022_0502 crossref_primary_10_23736_S0026_4806_21_07809_5 crossref_primary_10_7759_cureus_9424 crossref_primary_10_1136_bmjopen_2020_044661 crossref_primary_10_54962_ankemderg_1163275 crossref_primary_10_1093_hmg_ddab125 crossref_primary_10_7759_cureus_11555 crossref_primary_10_3389_fmed_2020_00398 crossref_primary_10_13105_wjma_v9_i1_64 crossref_primary_10_1111_apt_15813 crossref_primary_10_4103_sjg_sjg_540_20 crossref_primary_10_1097_MD_0000000000026719 crossref_primary_10_1093_ofid_ofab201 crossref_primary_10_23736_S0031_0808_21_04239_7 crossref_primary_10_1002_jmv_26411 crossref_primary_10_1038_s41598_021_99470_y crossref_primary_10_1097_MRM_0000000000000267 crossref_primary_10_1097_MD_0000000000028499 crossref_primary_10_1111_sji_13039 crossref_primary_10_1038_s41591_020_1025_y crossref_primary_10_2147_IJGM_S320713 crossref_primary_10_12998_wjcc_v8_i16_3405 crossref_primary_10_3390_molecules25245905 crossref_primary_10_1177_01455613211038070 crossref_primary_10_4103_jpbs_jpbs_88_23 crossref_primary_10_1080_1120009X_2021_1899442 crossref_primary_10_3389_fmolb_2023_1164220 crossref_primary_10_1002_ygh2_455 crossref_primary_10_3390_biomedicines11113002 crossref_primary_10_1038_s41598_021_89513_9 crossref_primary_10_1515_almed_2022_0010 crossref_primary_10_1016_j_intimp_2023_110439 crossref_primary_10_1371_journal_pone_0265117 crossref_primary_10_1093_ckj_sfaa160 crossref_primary_10_1186_s41232_022_00205_x crossref_primary_10_4103_jodp_jodp_46_23 crossref_primary_10_12998_wjcc_v11_i10_2189 crossref_primary_10_3748_wjg_v28_i46_6599 crossref_primary_10_1016_j_jceh_2021_05_003 crossref_primary_10_1089_jir_2022_0185 crossref_primary_10_13105_wjma_v9_i2_192 crossref_primary_10_13105_wjma_v9_i2_193 crossref_primary_10_3389_fcimb_2021_667487 crossref_primary_10_2174_18749445_v15_e2207290 crossref_primary_10_1111_hepr_13541 crossref_primary_10_1111_jan_14558 crossref_primary_10_3889_oamjms_2020_5380 crossref_primary_10_1002_aid2_13260 crossref_primary_10_1002_jmv_26314 crossref_primary_10_5114_amsad_2022_115008 crossref_primary_10_2147_IJGM_S347291 crossref_primary_10_1016_j_jhep_2020_06_041 |
Cites_doi | 10.1016/j.jacc.2018.08.1038 10.1101/2020.01.23.20018549 10.1164/rccm.201908-1581ST 10.1056/NEJMoa2001316 10.1056/NEJMoa2001191 10.3201/eid1002.030741 10.1101/2020.02.03.931766 10.1016/j.coviro.2017.11.002 10.1001/jama.2020.1585 10.1056/NEJMoa2002032 10.1056/NEJMoa2001017 10.1016/S0140-6736(15)60454-8 10.3201/eid1002.030761 10.1016/S0140-6736(20)30183-5 10.1016/j.jhep.2019.02.014 |
ContentType | Journal Article |
Copyright | 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. Copyright © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
Copyright_xml | – notice: 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. – notice: Copyright © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
DBID | AAYXX CITATION NPM 7T5 H94 K9. 7X8 |
DOI | 10.1111/all.14309 |
DatabaseName | CrossRef PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1398-9995 |
EndPage | 1752 |
ExternalDocumentID | 32239761 10_1111_all_14309 ALL14309 |
Genre | article Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: Funds for the construction of key medical disciplines in Shenzhen – fundername: Bill and Melinda Gates Foundation – fundername: The National infectious diseases Clinical Research Center – fundername: Sanming Project of Medicine in Shenzhen funderid: SZSM201612014 – fundername: Sanming Project of Medicine in Shenzhen grantid: SZSM201612014 |
GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7T5 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4829-5349d294a1e361ab57a0c598cbe33a7f3355ee51d9d424d6fd1b2b8d48d35c0e3 |
IEDL.DBID | DR2 |
ISSN | 0105-4538 1398-9995 |
IngestDate | Fri Jul 11 06:27:17 EDT 2025 Fri Jul 25 04:07:31 EDT 2025 Wed Feb 19 02:30:40 EST 2025 Thu Apr 24 23:11:51 EDT 2025 Tue Jul 01 04:15:13 EDT 2025 Wed Jan 22 16:34:05 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | severe pneumonia epidemiological features severe acute respiratory syndrome coronavirus 2 corona Virus Disease 2019 |
Language | English |
License | 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4829-5349d294a1e361ab57a0c598cbe33a7f3355ee51d9d424d6fd1b2b8d48d35c0e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-9744-792X |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.14309 |
PMID | 32239761 |
PQID | 2422435621 |
PQPubID | 34098 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2385708741 proquest_journals_2422435621 pubmed_primary_32239761 crossref_primary_10_1111_all_14309 crossref_citationtrail_10_1111_all_14309 wiley_primary_10_1111_all_14309_ALL14309 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2020 |
PublicationDateYYYYMMDD | 2020-07-01 |
PublicationDate_xml | – month: 07 year: 2020 text: July 2020 |
PublicationDecade | 2020 |
PublicationPlace | Denmark |
PublicationPlace_xml | – name: Denmark – name: Zurich |
PublicationTitle | Allergy (Copenhagen) |
PublicationTitleAlternate | Allergy |
PublicationYear | 2020 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2004; 10 2018; 28 2019; 70 2020; 323 2018; 72 2020; 382 2020 2020; 395 2019; 200 2016; 68 2015; 386 e_1_2_9_11_1 Rossaint J (e_1_2_9_10_1) 2016; 68 National Health Commission of the People’s Republic of China (e_1_2_9_12_1) e_1_2_9_13_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 |
References_xml | – volume: 395 start-page: 497 year: 2020 end-page: 506 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet – volume: 382 start-page: 929 issue: 10 year: 2020 end-page: 936 article-title: First case of 2019 novel coronavirus in the United States publication-title: N Engl J Med – year: 2020 article-title: Clinical characteristics of coronavirus disease 2019 in China publication-title: N Engl J Med – volume: 28 start-page: 43 year: 2018 end-page: 52 article-title: Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host publication-title: Curr Opin Virol – volume: 72 start-page: 2231 issue: 18 year: 2018 end-page: 2264 article-title: Fourth universal definition of myocardial infarction (2018) publication-title: J Am Coll Cardiol – volume: 70 start-page: 1222 issue: 6 year: 2019 end-page: 2126 article-title: EASL clinical practice guidelines: drug‐induced liver injury publication-title: J Hepatol – volume: 386 start-page: 995 issue: 9997 year: 2015 end-page: 1007 article-title: Middle East respiratory syndrome publication-title: Lancet – year: 2020 – volume: 200 start-page: e45 year: 2019 end-page: e67 article-title: Diagnosis and treatment of adults with community‐acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America publication-title: Am J Respir Crit Care Med – article-title: Specific ACE2 expression in cholangiocytes may cause liver damage after 2019‐nCoV infection publication-title: bioRxiv – volume: 10 start-page: 334 issue: 2 year: 2004 end-page: 338 article-title: Clinical description of a completed outbreak of SARS in Vietnam, February–May, 2003 publication-title: Emerg Infect Dis – volume: 68 start-page: 49 issue: 1 year: 2016 end-page: 57 article-title: Acute kidney injury: definition, diagnosis and epidemiology publication-title: Minerva Urol Nefrol – volume: 10 start-page: 327 issue: 2 year: 2004 end-page: 333 article-title: Combining clinical and epidemiologic features for early recognition of SARS publication-title: Emerg Infect Dis – volume: 382 start-page: 727 issue: 8 year: 2020 end-page: 733 article-title: A novel coronavirus from patients with pneumonia in China, 2019 publication-title: N Engl J Med – volume: 323 start-page: 1061 issue: 11 year: 2020 end-page: 1069 article-title: Clinical characteristics of 138 hospitalization patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China publication-title: JAMA – volume: 382 start-page: 1199 year: 2020 end-page: 1207 article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia publication-title: N Engl J Med – ident: e_1_2_9_11_1 doi: 10.1016/j.jacc.2018.08.1038 – ident: e_1_2_9_2_1 – ident: e_1_2_9_4_1 doi: 10.1101/2020.01.23.20018549 – ident: e_1_2_9_8_1 doi: 10.1164/rccm.201908-1581ST – ident: e_1_2_9_3_1 doi: 10.1056/NEJMoa2001316 – ident: e_1_2_9_19_1 doi: 10.1056/NEJMoa2001191 – ident: e_1_2_9_14_1 doi: 10.3201/eid1002.030741 – ident: e_1_2_9_16_1 doi: 10.1101/2020.02.03.931766 – ident: e_1_2_9_15_1 doi: 10.1016/j.coviro.2017.11.002 – ident: e_1_2_9_6_1 doi: 10.1001/jama.2020.1585 – ident: e_1_2_9_7_1 doi: 10.1056/NEJMoa2002032 – ident: e_1_2_9_13_1 doi: 10.1056/NEJMoa2001017 – ident: e_1_2_9_18_1 doi: 10.1016/S0140-6736(15)60454-8 – volume: 68 start-page: 49 issue: 1 year: 2016 ident: e_1_2_9_10_1 article-title: Acute kidney injury: definition, diagnosis and epidemiology publication-title: Minerva Urol Nefrol – volume-title: Handbook of Prevention and Treatment of the Pneumonia Caused by the Novel Coronavirus (2019‐nCoV) ident: e_1_2_9_12_1 – ident: e_1_2_9_17_1 doi: 10.3201/eid1002.030761 – ident: e_1_2_9_5_1 doi: 10.1016/S0140-6736(20)30183-5 – ident: e_1_2_9_9_1 doi: 10.1016/j.jhep.2019.02.014 |
SSID | ssj0007290 |
Score | 2.6883676 |
Snippet | Background
The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood.
Methods... The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood. We analyzed the... BackgroundThe clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei Province are less understood.MethodsWe... The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood.BACKGROUNDThe... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1742 |
SubjectTerms | corona Virus Disease 2019 Coronaviruses COVID-19 epidemiological features Epidemiology Erythrocyte sedimentation rate Fever Hospitals Infectious diseases Patients severe acute respiratory syndrome coronavirus 2 severe pneumonia |
Title | COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.14309 https://www.ncbi.nlm.nih.gov/pubmed/32239761 https://www.proquest.com/docview/2422435621 https://www.proquest.com/docview/2385708741 |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1JT9wwFICfEIeKS0sLtAO0MhUHDg1KvCSxOCFaNCA2oU7FoVLkDYEYBcRMLj31J_Q39pfw7DgpW6Wqt0h-2Ww_-7P9FoB1l4vCMO9-xmmRcCNF4mfFRBbMyFQaroK72OFRPhzx_TNxNgNbnS9MGx-i33DzmhHGa6_gSk_uKbkaj1HNWXDe87ZaHohO_4SOKuL-CvJDwlGrY1Qhb8XT3_lwLnoCmA95NUw4u6_ge_eprZ3J1WYz1Zvmx6Mojv_5L_PwMoIo2W57zmuYcfUbeHEYj9oXYLRz_G3v8--fvzJJLmuiiA22HoimlnQWXM2ExAOeCbmICUjIdTP1KUDJsNHukpyELQvjPpGQqXsRRrtfvu4Mk5iDITG8pDIRjEtLJVeZY3mmtChUaoQsjXaMqeKcIa84JzIrLafc5uc201SXlpeWCZM6tgSz9XXt3gHhTEvJXYkEprgthBQonlLLtDD4SDeAja41KhMDlPs8GeOqW6hgNVWhmgbwsRe9aaNyPCe02jVpFRVzUiGRUCTEnGYDWOuLUaX8OYmqHdZchRQjirRE1hrA27Yr9G_B8c8THJZshAb9--ur7YODcLH876IrMEf9ej6YA6_C7PS2ce8Reqb6Q-jdd42w-ks |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9VAFD4hkKgbEF9cQByNCxaWtPNoO4kbgpKL3ovGcA0b08yLSLgphHu7YcVP4Df6SzwznVbxkRh3Tea003l8M9-cOQ-Aly4XhWHe_YzTIuFGisTvioksmJGpNFwFd7HxYT6c8HfH4ngBXne-MG18iF7h5pER1msPcK-Q_gnlajpFnDPvvbfkM3qHA9WnH8GjiqhhQQaRcMR1jCvk7Xj6V2_vRr9RzNuMNWw5-yvwpfvZ1tLkbKeZ6x1z9Uscx_9tzX1YjlyU7LaTZxUWXP0A7ozjbftDmOx9-Hzw5tv1TSbJaU0UscHcA9mpJZ0RVzMj8Y5nRr7GHCTkvJn7LKBk2Gh3Sj4GrYVxr0hI1v0IJvtvj_aGSUzDkBheUpkIxqWlkqvMsTxTWhQqNUKWRjvGVHHCkLI4JzIrLafc5ic201SXlpeWCZM69hgW6_ParQHhTEvJXYkkTHFbCClQPKWWaWHwk24A291wVCbGKPepMqZVd1bBbqpCNw3gRS960Qbm-JPQZjemVcTmrEJSQpEk5jQbwPO-GFHlr0pU7bDnKiQyokhLpFsDeNLOhb4WXAI9icOS7TCif6--2h2NwsP6v4s-g7vDo_GoGh0cvt-Ae9Qf74N18CYszi8b9xQ50Fxvhan-HTFx_mY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2qilSxoUB5DBTqIhZdkCrxI4nFquowmsK0VIhBXSBFfo2oOkorZrJh1U_oN_IlXDtOaHlIiF0k38SxfY99bN8HwEuXi8Iw737GaZFwI0XiV8VEFszIVBqugrvY4VE-nvK3J-JkBV53vjBtfIj-wM0jI8zXHuAXdnYN5Go-R5gz77x3i-dp6VV6-OFn7KgiHrAggUg4wjqGFfJmPP2rNxej3xjmTcIaVpzROnzu_rU1NDnbbZZ613z7JYzjfzbmLtyJTJTstapzD1ZcfR_WDuNd-wZM999_Ohh-v7zKJDmtiSI2GHsgN7WkM-FqFiTe8CzIl5iBhJw3S58DlIwb7U7JcTizMO4VCam6H8B09Obj_jiJSRgSw0sqE8G4tFRylTmWZ0qLQqVGyNJox5gqZgwJi3Mis9Jyym0-s5mmurS8tEyY1LGHsFqf1-4xEM60lNyVSMEUt4WQAsVTapkWBj_pBrDTjUZlYoRynyhjXnU7FeymKnTTAF70ohdtWI4_CW12Q1pFZC4qpCQUKWJOswFs98WIKX9RomqHPVchjRFFWiLZGsCjVhX6WnAC9BQOS3bCgP69-mpvMgkPT_5ddAvWjoejanJw9O4p3KZ-bx9Mgzdhdfm1cc-QAC3186DoPwBRqf0e |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID%E2%80%9019+in+a+designated+infectious+diseases+hospital+outside+Hubei+Province%2C+China&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Cai%2C+Qingxian&rft.au=Huang%2C+Deliang&rft.au=Ou%2C+Pengcheng&rft.au=Yu%2C+Hong&rft.date=2020-07-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0105-4538&rft.eissn=1398-9995&rft.volume=75&rft.issue=7&rft.spage=1742&rft.epage=1752&rft_id=info:doi/10.1111%2Fall.14309&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |